Calimot, Madel L.
HRN: 22-02-71 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
CEFUROXIME 1.5GM (VIAL)
01/05/2024
01/06/2024
IV
1.5g
Q8
IUFD; WBC 20.7
Waiting Final Action
01/05/2024
CEFUROXIME 500MG (TAB)
01/06/2024
01/12/2024
PO
500mg
BId
IUFD; Wbc: 20.7
Waiting Final Action
01/05/2024
CEFUROXIME 500MG (TAB)
01/06/2024
01/12/2024
PO
500mg
BId
IUFD; Wbc: 20.7
Waiting Final Action